NCT06839846 Survey of Different Modes of Weaning in Pediatric Population
| NCT ID | NCT06839846 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Weaning |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-04-01 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Infant weaning refers to the transition from a diet based on the exclusive intake of milk (mother's milk or formula) to a diversified diet that is complete with all the nutrients necessary for proper infant development. For this purpose, a diet supplementary to milk, which is gradually reduced, is undertaken in order to gradually acquire the dietary pattern followed by the family. There are different types of weaning, which vary according to traditions, ethnicity and scientific currents. These include traditional weaning and on-demand self-weaning. The former consists of weaning with specific infant foods (example: freeze-dried, homogenized, vegetable broth, creams..) offered at set doses, quantities, and times. On the other hand, 'autodivezzamento on demand is a mode of weaning entrusted to the child's request, leaving the child to choose quantities and types of food, even prepared at home, during family meals. The aim of our study is to establish the prevalence of different modes of weaning and the perception of advantages and disadvantages related to them by parents and Free Choice Pediatricians by means of two different dedicated questionnaires. The study also aims to assess possible risks resulting from the transition to complementary feeding, for example, errors in feeding or inhalation of foreign bodies.
Eligibility Criteria
Inclusion Criteria: Parents group: * Overage parents with children between the ages of 4 and 18 months * Need to have an electronic tool that allows direct access to the link connected to an internet network * Understanding of the Italian language * Obtaining informed consent from the parent completing the questionnaire Pediatricians group: * Activities of Free Choice Pediatrician in Italy. * Need to have an electronic tool that allows direct access to the link connected to an Internet network * Obtaining informed consent Exclusion Criteria: Parents group: \- Parents of children with chronic neurological diseases, dysphagia, chronic diseases involving specific diet, intestinal diseases resulting in malabsorption; Pediatricians group: \- None
Contact & Investigator
Arianna Dondi, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06839846 clinical trial?
This trial is open to participants of all sexes, studying Weaning. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06839846 currently recruiting?
Yes, NCT06839846 is actively recruiting participants. Contact the research team at arianna.dondi@aosp.bo.it for enrollment information.
Where is the NCT06839846 trial being conducted?
This trial is being conducted at Imola, Italy, Carpi, Italy, Bologna, Italy, Bologna, Italy.
Who is sponsoring the NCT06839846 clinical trial?
NCT06839846 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Arianna Dondi, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 500 participants.